MIPL - CANCER SCREENING PACKAGE MEN
MRP - ₹ 6,939 4,900
About the package:
The Cancer Screening Package for Men is a comprehensive diagnostic program designed for early detection of common cancers. It includes a panel of routine blood and biochemical tests, inflammation and immune markers, hormone/function assessments, and specific tumor-marker evaluations tailored to male health. This package screens for risk factors and early signs associated with prostate, lung, colorectal, liver, thyroid, and other cancers. Regular screening helps identify abnormalities before symptoms develop, enabling timely follow-up, diagnosis, and treatment—measures that substantially improve outcomes and long-term well-being.
Additional Information
| Tests: | KIDNEY PANEL KFT BASIC, LIVER PANEL LFT BASIC, THYROID PROFILE TOTAL ( T3T4 & TSH), COMPLETE BLOOD COUNT WITH ESR (CBC+ESR), C-REACTIVE PROTEIN; CRP, PSA TOTAL (PROSTATE - SPECIFIC ANTIGEN), CEA CARCINO EMBRYONIC ANTIGEN, AFP (ALPHA FETOPROTEIN) TUMOR MARKER, PSA (PROSTATE - SPECIFIC ANTIGEN) FREE |
| Parameters: | 60 |
| Recommended for: | Male |
| Sample Type: | Blood |
| Patient Preparation: | 1. 4 hours of fasting is required. Avoid fatty food in the last meal prior to the test (for blood test & USG). 2. A full bladder is required, please do not pass urine before the scan(for usg) 3. Patient to carry prescription & previous records (if any) |
| Reports: | Within 24 working hours |
| Purpose: | To assess early detection of common cancers in men, promoting timely interventions and improved health outcomes. |
FAQs
Highly recommended for men over 40, those with family history of cancer, or at higher risk due to factors like smoking, obesity, consultation with your healthcare professional is needed.
Typically every 1-2 years for average-risk men over 40; more frequently if high-risk or previous abnormalities; follow personalized medical advice by your healthcare professional.
The tests included in this package are standard diagnostic investigations, widely performed, and considered safe with negligible risk.
A CBC checks blood cells for anemia or cancers; while CRP and ESR measure inflammation, potentially indicating infections, autoimmune issues, or malignancies.
These measure prostate-specific antigen levels; elevated PSA may indicate prostate cancer or benign issues, crucial for early prostate screening in men.
